• No image available for this medication
    • PYRUKYND

    • QTY 14
    • 20 MG
    • Tablet
    • Near  77381

MITAPIVAT (mye ta PIV at) treats hemolytic anemia caused by pyruvate kinase deficiency. It works by stopping red blood cells from breaking down too quickly. This decreases symptoms and the need for blood transfusions.


PYRUKYND Lifestyle Interactions

  • Mitapivat 20mg, Oral tablet

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not drink grapefruit juice or eat grapefruit or grapefruit-containing foods while taking mitapivat. Side effects from mitapivat may get worse. Contact your prescriber immediately if you experience any new or unusual side effects.
    Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during mitapivat treatment due to the risk of increased mitapivat exposure and adverse reactions. Mitapivat is a CYP3A substrate and grapefruit juice is a strong CYP3A inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.